Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from C-Rad AB Class B ( ($SE:CRAD.B) ) is now available.
C-RAD has announced an advancement in the approval process for its interim report for the third quarter of 2025, following recent management changes. The board meeting to approve the report has been moved up, with distribution planned for October 21, 2025, and an investor presentation scheduled for October 23, 2025, indicating proactive steps in company operations and communication with stakeholders.
The most recent analyst rating on ($SE:CRAD.B) stock is a Hold with a SEK35.00 price target. To see the full list of analyst forecasts on C-Rad AB Class B stock, see the SE:CRAD.B Stock Forecast page.
More about C-Rad AB Class B
C-RAD is a company that specializes in developing surface-guided imaging solutions for radiation therapy. Their technology focuses on delivering highly accurate doses to tumors while protecting healthy tissue, utilizing high-speed 3D cameras and augmented reality for patient setup and motion monitoring. C-RAD’s solutions aim to enhance patient safety and comfort without additional imaging doses.
Average Trading Volume: 40,835
Technical Sentiment Signal: Sell
Current Market Cap: SEK1.12B
See more insights into CRAD.B stock on TipRanks’ Stock Analysis page.